250 related articles for article (PubMed ID: 6825033)
1. High-dosage isosorbide dinitrate therapy for angina.
Tremblay G; Biron P; Désourdy F
Can Med Assoc J; 1983 Mar; 128(6):679-81. PubMed ID: 6825033
[TBL] [Abstract][Full Text] [Related]
2. High-dose isosorbide dinitrate in management of angina pectoris.
Tremblay G
Am Heart J; 1985 Jul; 110(1 Pt 2):280-4. PubMed ID: 3925747
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation using serial exercise tests of verapamil alone and combined with isosorbide dinitrate in exertional angina].
Vázquez de Prada JA; Ruano J; Zueco J; Colman T; González-Vílchez F; Pajarón A
Rev Esp Cardiol; 1989 Oct; 42(8):513-8. PubMed ID: 2602607
[TBL] [Abstract][Full Text] [Related]
4. [The noninvasive identification of patients with angina and normal coronary arteries].
Rusticali G; Di Clemente D; Ruggeri A; Borghi A; Bugiardini R
G Ital Cardiol; 1995 Sep; 25(9):1161-70. PubMed ID: 8529853
[TBL] [Abstract][Full Text] [Related]
5. A comparison of nifedipine and isosorbide dinitrate in angina pectoris with particular reference to arterial oxygen saturation.
Tirlapur VG; Mir MA
Postgrad Med J; 1983; 59 Suppl 2():30-4. PubMed ID: 6136959
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of antianginal efficacy of long-term therapy with low dose isosorbide dinitrate in patients with stable angina pectoris].
Kośmicki M; Sadowski Z
Przegl Lek; 2000; 57(9):455-8. PubMed ID: 11199864
[TBL] [Abstract][Full Text] [Related]
7. [Dose-effect relationship of isosorbide dinitrate in the treatment of angina pectoris (author's transl)].
Schneider W; Stahl B; Kaltenbach M; Bussmann WD
Dtsch Med Wochenschr; 1982 May; 107(20):771-6. PubMed ID: 7075499
[TBL] [Abstract][Full Text] [Related]
8. [Influence of combination therapy (isosorbide dinitrate and molsidomine) on the incidence of angina pectoris in patients with coronary heart disease].
Ciopor M; Fischer A; Turina J; Hess OM
Praxis (Bern 1994); 1997 Nov; 86(47):1849-53. PubMed ID: 9480502
[TBL] [Abstract][Full Text] [Related]
9. [Development of nitrate tolerance in individual patients with stable angina pectoris in various phases of therapy with oral isosorbide dinitrate].
Kośmicki M; Szwed H; Kowalik I; Sadowski Z
Pol Merkur Lekarski; 2002 Jul; 13(73):52-5. PubMed ID: 12362508
[TBL] [Abstract][Full Text] [Related]
10. The antianginal efficacy of isosorbide dinitrate: dose-response relation and long-term effects of high-dose treatment.
Schneider W; Bussmann WD; Stahl B; Wietschoreck A; Kaltenbach M
Z Kardiol; 1985; 74 Suppl 1():55-63. PubMed ID: 3922143
[No Abstract] [Full Text] [Related]
11. [Comparative evaluation of antianginal efficacy of isosorbide dinitrate in various doses in patients with stable angina].
Kośmicki M; Sadowski Z
Wiad Lek; 2000; 53(7-8):388-93. PubMed ID: 11070759
[TBL] [Abstract][Full Text] [Related]
12. Effect of intervals between doses on the development of tolerance to isosorbide dinitrate.
Parker JO; Farrell B; Lahey KA; Moe G
N Engl J Med; 1987 Jun; 316(23):1440-4. PubMed ID: 3574424
[TBL] [Abstract][Full Text] [Related]
13. Effects of long-term molsidomine treatment versus isosorbide dinitrate and placebo on exercise tolerance in stable angina.
Romano M; de Caprio L; Meccariello P; Cuomo S; Baldini F; D'Ascia C; Steinberg G; Chiariello M
Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):246-9. PubMed ID: 6430811
[TBL] [Abstract][Full Text] [Related]
14. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease.
Winkelmann BR; Matheis G; Kleist P; Pötter S; Wohltmann D; Kaltenbach M
Coron Artery Dis; 1994 Oct; 5(10):829-44. PubMed ID: 7866603
[TBL] [Abstract][Full Text] [Related]
15. Nitrate tolerance.
Parker JO
Herz; 1984 Jun; 9(3):137-45. PubMed ID: 6430767
[TBL] [Abstract][Full Text] [Related]
16. Clinical effects of a sustained-release preparation of isosorbide dinitrate on angina pectoris.
Arakawa K; Fujino M
Clin Ther; 1980; 3(2):103-16. PubMed ID: 6778614
[TBL] [Abstract][Full Text] [Related]
17. An open, long-term, multi-centre study of the anti-anginal efficacy and safety of isosorbide 5-mononitrate at low doses in patients with coronary heart disease.
Uberbacher HJ; Steinorth G; Glocke M; Abshagen U
Pharmatherapeutica; 1983; 3(5):331-41. PubMed ID: 6342004
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of dinitrate isosorbide retard forms in ischemic heart disease patients with stable effort angina].
Lupanov VP; Alekseeva IA; Vasil'eva NN; Komar OA; Romasiuk SS; Naumov VG
Ter Arkh; 2000; 72(9):33-6. PubMed ID: 11076413
[TBL] [Abstract][Full Text] [Related]
19. Sustained antianginal efficacy of oral high-dose isosorbide dinitrate in patients with coronary heart disease.
Schneider W; Wietschoreck A; Bussmann WD; Kaltenbach M
Z Kardiol; 1983; 72 Suppl 3():259-67. PubMed ID: 6666231
[TBL] [Abstract][Full Text] [Related]
20. Sustained hemodynamic and antianginal effects of high dose oral isosorbide dinitrate.
Aronow S
Nouv Presse Med; 1980 Sep; 9(34 Suppl):2483-6. PubMed ID: 7422537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
